Population Council

Knowledge Commons

2019

Health financing and family planning in the context of Universal
Health Care: Connecting the discourse
Gabrielle Appleford
Saumya RamaRao
Population Council

Follow this and additional works at: https://knowledgecommons.popcouncil.org/departments_sbsr-rh
Part of the Demography, Population, and Ecology Commons, Family, Life Course, and Society
Commons, Health Policy Commons, and the International Public Health Commons

How does access to this work benefit you? Let us know!
Recommended Citation
Appleford, Gabrielle and Saumya RamaRao. 2019. "Health financing and family planning in the context of
Universal Health Care: Connecting the discourse." brief. New York: Population Council.

This Brief is brought to you for free and open access by the Population Council.

HEALTH FINANCING AND FAMILY PLANNING IN
THE CONTEXT OF UNIVERSAL HEALTH CARE:
CONNECTING THE DISCOURSE
INTRODUCTION
Financing is a major challenge and concern for
the future of family planning (FP) programs. As
countries commit to increasing access to and
quality of FP services and to universal health
care (UHC), it is crucial that UHC schemes
include FP and other reproductive health (RH)
services. Strategic purchasing of quality FP
services from public and private - including for
profit and not-for-profit - healthcare providers
could accelerate progress toward UHC.
It is increasingly recognized that the FP2020
goals will not be met without adequate attention
to quality; and that a sustained focus on quality
of care requires financing at the policy and program levels. While the importance
of financing is recognized in relation to quality, the ‘how’ of financing FP within the
context of UHC is not well understood.
This brief targets the ‘bridge’ constituency that is coalescing between the health
financing and FP communities of practice around a shared interest in making access
to health services universal. With this brief, we aim to:

•

Document trends in UHC and health financing, drawing out implications for policy
makers and programmers

•

Identify opportunities for the FP community of practice to advocate for the inclusion of quality FP services within UHC and health financing discussions

METHODOLOGY AND OUTLINE

MARCH 2019

This technical brief drew on selected published and grey literature on health financing,
FP and UHC. The technical brief is divided into four sections:

•

Section one outlines salient features of health financing and UHC as well as related
trends

•

Section two outlines health financing for FP, current emphasis of financing efforts
and the evidence base

•

Section three outlines strategic purchasing and FP and its relationship with quality
FP services

•

Section four proposes an organizing framework for strategic purchasing for FP,
outlining purchasing elements and FP considerations
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SECTION 1. HEALTH FINANCING AND UHC
- SALIENT FEATURES
Health systems financing has specific functions and objectives. Financing functions are threefold – revenue generation, risk pooling and strategic purchasing (WHO, 2010).
Health financing functions are intended to achieve specific
objectives – generate sufficient and sustainable financing,
improve the efficiency and quality of health services, and expand access to high quality services in a client-centered and
responsive manner (WHO, 2016). Health financing functions
and objectives are inter-related; success or failure in one has
implications for ‘effective coverage’, which is the probability
that someone who needs an intervention will get it and have
their health improved as a result (Sparks et al, 2016).

(DAH). Greater reliance on domestic financing has been
prompted by stagnation of donor funding. Since 2010,
stagnation has characterized DAH across all health
focus areas. Past trends and associations suggest that
this stagnation might be the new reality, rather than just
a temporary anomaly (Dieleman et al, 2016). There is
recognition that while DAH remains an important source
of health financing in many LMIC, it must contribute to
domestic resource mobilization rather than crowd it out
(Evans and Pablos-Méndez, 2016). This has prompted
some donors, such as USAID, to focus on how to responsibly transition financing and support country health
systems on a trajectory toward full domestic financing
(USAID, 2018).

UHC is the articulation of health financing aims, as expressed in national health strategies. UHC seeks to ensure
that all citizens should receive the health services that they
need without financial hardship, in recognition of the intrinsic
value of health and basic human rights to self-determination,
dignity, and equality. Progress toward UHC is measured by
the coverage of key services and financial protection. While
there is no single authoritative formulation of UHC (Ooms et
al, 2014), in many countries, UHC includes national health
insurance (and is often taken as shorthand for this) and
entitlement schemes, such as free maternal and child health
services (Maeda et al, 2014). These may be in addition to
public financing of service provision through budget lineitems and other forms of health service purchasing.

• Emphasis on efficiency measures. Given the limitations

The drive for UHC has been accompanied by other trends in
donor assistance, health financing, and health systems organisation. These trends are not smooth or necessarily linear
and include the following:

das share the same objective of maximizing the benefit
derived from available resources and ensuring public
health impact. However, these agendas may work at
cross purposes as poor-quality services generate additional costs, through the underuse, overuse, and misuse
of interventions and services, while financing arrangements may impede improvements in care (McLoughlin
and Leatherman, 2003). There is evidence that financing arrangements strongly influence how institutional
providers (hospitals and health systems) and individual
healthcare workers provide health services (McLoughlin
and Leatherman, 2003).

• Increased focus on domestic financing. There is increasing emphasis on domestic financing, particularly as
countries transition from low- to middle-income country
(LMIC) status. Despite this emphasis, many sub-Saharan
African countries spend less than 15% of their government budget on health (the Abuja Declaration target),
and in many cases, these proportions are either stagnating or declining over time. Furthermore, as countries
graduate from low- to middle-income, greater reliance on
domestic financing does not necessarily translate into increased ‘funding for health’ and may be accompanied by
widening inequities between the rich and poor (Xu et al,
2011). Out-of-pocket (OOP) expenditure has continued
to feature as part of domestic financing and comprises
over 40% of average total health expenditure in low-income countries (WHO, 2017). Gendered inequities in
service access and the disproportionate barrier that OOP
spending creates for women and adolescent girls is rarely recognised or analyzed as part of domestic financing
(Witter et al, 2017).
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• Stagnation in development assistance for health

of domestic financing and a context of stagnating DAH,
there has been greater attention to efficiency in service
provision. These efforts include allocation of resources
toward services and inputs that generate better results
at lower cost, pooling of funds, increasing transparency
and accountability, strategic purchasing, and strengthening managerial capacities at both government and
facility level (World Bank, 2017). Strategic purchasing is
viewed as a means of improving quality and efficiency.
However, poor targeting, inadequate use of evidence,
and fragmented financing may continue to reduce the
efficiency of existing investments (Lie et al, 2015).

• Quality of care. The financing and quality of care agen-

• Integrated service delivery and primary health care.
There have been efforts to move away from vertical,
single health service focused programs, to integrated
health services across the life cycle, using primary
health care (PHC) as the organizing framework. However,
the content of PHC, both in terms of which interventions are included and which are priorities for universal
access—has shifted over time (Lawn et al, 2008) and
may present as competing discourses. For example, the
economic emphasis of UHC on domestic financing have
conflated it with insurance, may make it vulnerable to
political and financial pressure and privilege clinical over

public health interventions (Hill, 2018; Schmidt et al,
2015). Additionally, less powerful groups, such as poor
women, who have higher health needs and lower financing capabilities than men, may not be prioritized (Witter
et al, 2017).
Health financing and service organisation trends have
implications for FP. In many LMICs, efforts to increase FP
financing operate in parallel with the development of UHC
schemes and essential benefits packages (Mazzili et al,
2016; Appleford and Camara, 2018). Given this, as countries
reorganize their health financing functions, there is a risk
that they insufficiently cover vulnerable populations, such as
poor women and adolescent girls and boys, or fail to include
priority services such as FP. This puts FP at risk of being left
out of benefits packages and related UHC schemes.

SECTION 2. HEALTH FINANCING AND
FAMILY PLANNING
FP financing comes from a range of sources, including
international donors, national governments, NGOs and
clients - the latter, in the form of OOP expenditure. FP has
enjoyed ‘special attention’ through efforts such as FP2020
and the World Bank’s Global Financing Facility (GFF), which
supports governments to address a broad spectrum of
intervention on the reproductive, maternal, neonatal, child
and adolescent health (RMNCAH) continuum as part of the
Global Strategy for Women’s, Children’s and Adolescents’
Health. Other dedicated sources of FP financing are limited, due to a contraction of DAH in general as well as shifts
in the political landscape that have created an uncertain
funding environment for FP (e.g. the Mexico City Policy, and
shifting donor priorities, notably USAID). Financing through
client OOP expenditure is also a significant contributor to
FP financing. It is estimated that OOP comprises nearly half
(49%) of the costs of reproductive, maternal, neonatal, and
children’s health (Lie et al, 2015) and will account for most
of the financing for FP over the next three years (RHSC,
2018). This form of financing may not be recognised as a
barrier to access as it may not be viewed as catastrophic or
a financial hardship for women and girls. As a result, it may
also not be prioritized by the FP community, given other
supply- side and demand-side barriers (Lie et al, 2015).
While the FP community of practice recognises the
importance of sustainable financing, including domestic
financing, commodities have dominated the discussion
and policy priorities. This is an important piece of health
financing for FP, given predicted funding gaps for commodities (RHSC, 2018). It is also the most visible as ‘tracking
of domestic financing is easiest for commodities since this
usually entails a budget line item.’ (FP2020, 2018). As a
result, there are several agencies and technical working
groups focused on the establishment - and replenishment

- of budget lines for FP commodities. There has also been
emphasis placed on a Total Market Approach (TMA), to
increase access to priority health products, such as FP
commodities, in a sustainable manner (K4Health, 2018).
This approach seeks to direct subsidies towards those most
in need while allowing the commercial sector to cater for
those willing to pay for FP commodities and services.
Beyond FP commodities, expenditure tracking tends to
focus on vertical FP financing or is reliant upon efforts to
disentangle FP service elements from government RH
accounts. This approach is employed by FP2020, through
its single financing indicator that tracks progress on annual
expenditure on FP from government domestic budgets
(FP2020a, 2018). Tracking is to be aided by national FP
costed implementation plans (CIPs), ‘multi-year actionable
roadmaps designed to help governments achieve their
family planning goals.’ (FP2020a, 2018). These tend to be
standalone documents, not integrated into broader health
planning tools, program requirements, or government budgets. Some of these have been produced at a sub-national
level given decentralization of health services, which may
further compound FP expenditure tracking.
The vertical framing of FP financing tends to position FP
as in competition with other essential health services. This
often does not win sympathy with health financing counterparts and runs counter to health systems objectives, such
as improved efficiency and service integration. In some
countries, vertical FP financing is reflective of historical policies on population programs. In Bangladesh, for example, a
separate directorate for FP and an independent Division of
Population Control and FP was established in the Ministry
of Health and Family Welfare (MoHFW) in 1975 and has
retained separate financing and structures at national and
sub-national levels (Bangladesh MoHFW, 2018). While vertical structures may not exist in other contexts, there remains
some uneasiness with integration, as FP may ‘get lost’ in
RMNCAH programs or forgotten altogether. For example,
Marie Stopes International health financing assessments
from West Africa have highlighted that contraception has
frequently remained a fee-payable service in private and
public facilities despite growing exemption schemes for
maternal and child health (Mazzilli et al, 2016).
The FP community may also reinforce a siloed approach
to quality and rights rather than employ a broader UHC
frame of reference. The rights-based FP agenda and efforts
to measure this are reflective of this approach. While there
tends to be emphasis on rights at the point of service
delivery (e.g. three FP2020 indicators address this), the
conditions for rights-based FP are better addressed within
and outside the health sector at political, institutional and
communal levels, including work to address women’s and
adolescents’ agency - supported through efforts to address
gender equality (Ferguson and Desai, 2018). While rights
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are observed in provider-client interactions and can be measured to a degree, they do not start with these interactions.
Rights-based FP is implied based on observable conditions
in which clients seek services, providers operate, or policy
signals that enable or acknowledge human rights in FP.
Signal strength, such as commitment to UHC or adequate
and predictable financing, can have a powerful but indirect
effect on FP service delivery. Applying a systematic rights
framework to the design, implementation, and evaluation
of health financing initiatives, including but not exclusively
quality measures could strengthen FP services and help to
move beyond the siloed approach to quality and rights (Cole
et al, 2018; Boydell et al, 2018).
The lack of ‘common language’ has been recognised
by the FP community of practice as an obstacle to the
effective inclusion of FP within health financing and UHC.
This, at times, has been underpinned by conflicting or
poorly communicated objectives but may also reflect a lack
of capacity and tools to facilitate such engagement (Abt
Associates, 2016). Some organisations have responded by
increasing the use of market and systems-based analysis
while others have developed outward facing platforms to
deepen engagement on this subject (Abt Associates, 2016).
These have been positioned as building health financing for
FP ‘literacy’ but may still promote FP-specific language such
as TMA.
There have been some recent efforts to analyse FP that
explore broader financing mechanisms.

4

•

This has included systematic reviews of specific financing models (and their effective inclusion of FP), such
as community financing and community-based health
insurance (Karra et al, 2016), conditional and unconditional cash transfers (Khan et al, 2016), introducing,
removing, or changing OOP or user fees (Korachais
et al, 2016), results-based financing (Blacklock et al,
2016), performance-based incentives (Bellows et al,
2014), and social protection programs that provide a
voucher subsidy (Bellows et al, 2016). A summary of
the systematic reviews concluded that there is ‘limited
scientific evidence on the effectiveness of the various
financing mechanisms for contraception’ and that more
robust studies are required (Lissner and Ali, 2016).
This was evidenced by the lack of quality and methodological rigor in the 17,000 papers identified through
the systematic reviews, with only 702 selected for full
text review and only 38 meeting inclusion standards, or
0.2% of all papers.

•

Other studies have focused on the inclusion of FP
within UHC oriented schemes in ‘transition’ health
financing contexts. For example, a study conducted by
Fagen et al (2017) examined FP within social health insurance schemes in nine Latin America and Caribbean
(LAC) countries and found that FP services have been

relatively well-integrated into UHC-oriented schemes in
these contexts; that enrollment in government supported insurance schemes (rather than reliance on free
provision through public health facilities) was associated with improved access to and uptake of modern FP
methods; and, among the poorest quintile of women,
insured women had a modern contraceptive prevalence rate 16.5 percentage points higher than those
that were uninsured.

•

More recently, a seven-country study (Ross et al, 2018)
concluded that despite the formal inclusion of FP services in national benefits packages examined, actual
integration of these services has faced challenges
where issues such as unauthorized fees, lack of capacity, and limited political will, have limited the availability
of FP services in practice. The study concluded that
payment mechanisms need to be evaluated to assess
incentivization of FP services through insurance while
reliance on public facilities as sole affiliated providers
for many insurance schemes may limit utilization due
to low client confidence and the perception of higher
quality in the private sector. In many of the analyzed
countries, client confidence in the public sector is low
and people may prefer to pay for services from private
providers who offer, or are perceived as offering, higher-quality services.

These works and other efforts have attempted to make
the ‘special case’ for FP within health financing and
UHC schemes. These considerations include the range of
commodities and competencies required to deliver high
quality contraceptive services. These span methods that
are self-administered to surgical procedures, making FP
unique amongst primary health and preventative services.
This range is also reflective of cadres and service levels
in which FP is delivered, from community-based to higher
levels of care. The political and stigmatized nature of FP
and other sexual and reproductive health (SRH) services is
also unique amongst PHC services. These emanate from
within the health system as well as the wider socio-ecology and may include the FP community itself. For example,
concerns related to coercion and choice may influence how
the FP community approaches financing, in the belief that
this should promote all methods equally and not single out
any specific method(s) for attention. LARCs for example
may require differential payment mechanisms, given the
additional counseling, clinical competency and consumables required for the delivery of these services. A best
practice guidance advises ‘don’t compensate for delivery of
specific FP methods with payments that are out of line with
payments for other services, as this may lead to coercive
behavior and should be avoided’ (Eichler et al, 2018) suggesting that differential payment may be supported, if this
is in line with other services.

SECTION 3. FP AND STRATEGIC
PURCHASING
FP financing studies, such as those summarized in the
previous section, reflect the combinations of input and
output-based financing that exist for FP. Some of these
are integrated with other PHC services while others may be
FP specific mechanisms. While these tend to be studied in
isolation, in practice, they operate concurrently, if not coherently. Sources of FP purchasing may include:

•

Contraceptive commodity procurement through a centralized government body using domestic and/or donor
financing.

•

Purchasing of healthcare services, including FP, from
public health facilities through line-item budgets. This
is often referred to as passive purchasing as national
governments may allocate budgets based largely on
funding received the previous year.

•

Purchasing of health care services, including FP, from
public and private health facilities through national
health insurance on behalf of registered members or
entitlement schemes, such as free maternity care.
Often this form of purchasing is referred to as strategic,
or more active purchasing, as it is based on some form
of output, such as the number of deliveries attended or
other health-related outcomes.

•

Results-based financing (RBF) often entails financing
from donors (such as the World Bank and the GFF),
channeled through the Ministry of Finance to purchase
services mainly from public health facilities, but may
also include the private sector. In these schemes, FP is
generally included as one of several RMNCAH priority
services. Reimbursements are based on results in the
form of incentives for reported outputs and quality indicators. RBF relies upon other inputs such as commodities, staff and infrastructure.

The array of FP financing points serves to illustrate that
a narrow focus on commodities or line item budgets may
miss other potential sources of FP purchasing. These may
be more important over time, particularly if these are positioned as the main vehicles for UHC, as in the case of national health insurance in many contexts. Lessons emerging
from Mexico and Thailand suggest that progress towards
UHC in terms of developing effective financing mechanisms
needs to be accompanied by attention to services which
predominately affect women, such as SRH, and efforts to
tackle the underlying political and social determinants that
undermine access for vulnerable and marginalized groups,
such as poor and marginalised women and adolescents
(Witter et al, 2017). Where FP and other SRH services
have been effectively included in national health insurance

schemes, this has been associated with improved access to
and uptake of modern FP methods, as demonstrated in the
LAC region (Fagan et al, 2017).
Ideally, more ‘active’ strategic purchasing for FP and
other PHC services, drawing from a range of mechanisms,
should be implemented and efforts taken to ensure that
these operate coherently. This is the premise of strategic
purchasing, defined as the ‘continuous search for the best
ways to maximise health system performance by deciding
which interventions should be purchased, how, and from
whom’ (RESYST, 2014). The ‘how’ or mechanisms through
which payments for specific services are made can be an
important determinant of whether and how well services
are provided (McLoughlin and Leatherman, 2003). In the
case of FP, research shows that contraceptive discontinuation decreases, and contraceptive use increases with
improved quality of care (Jain et al, 2017; Jain and Winfrey,
2017). ‘Who’ these payments are made to equally matters.
In the case of the public sector, payment may not make its
way to the health facilities delivering the services, further
constraining whether and how well services are provided.
The private sector may also be excluded. Considerations
such as these are critical to FP given that contraceptive
discontinuation accounted for about 38% of women with
unmet need and accounted for about 35% of unintended
pregnancies (Jain et al, 2017; Jain and Winfrey, 2017).

SECTION 4. FP AND FINANCING BRINGING IT ALL TOGETHER
There are well known reasons for investing in FP. FP saves
money, saves lives and generates broader societal benefits (Singh et al, 2009). While known to the FP community,
these may not be apparent to health financing audiences.
Therefore, how FP investment is approached and articulated by the FP community needs to resonate with broader
UHC and health financing objectives. These are contextually defined, underpinned by a country’s UHC plans and
schemes. Not engaging with this wider frame of reference
reinforces a siloed approach to FP financing that may work
against FP2020 objectives of increasing domestic financing
in the long run. It may further position FP as in competition
to other PHC services and health systems objectives, such
as service integration.
How FP is included in UHC and health financing matters.
Adequate financing has implications for universality and equity. This is a matter of rights, given the differential health
risks and needs that women face, including unwanted pregnancy. How FP services are compensated under UHC also
matters and should balance incentives for efficiency with
incentives for appropriate provision using the rights-based
approach to user-centered care so that risks of sub-optimal
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TABLE 1. Strategic purchasing and FP
Purchasing domains

Purchasing elements

FP considerations

Polities: Why to purchase (rationale
and institutional arrangements)

•
•
•

•

•
•

Political commitment
Institutional arrangements
Purchaser alignment (across
mechanisms)
Monitoring and accountability
Performance management

•
•
•
•

People: For whom to purchase

•
•
•

Defined target clientele
Clientele awareness
Community and society
engagement

•
•
•
•

Package: What to purchase

•
•

Defined benefit objectives
Defined benefit package

•
•

Societal benefits (FP rights,
gender equality)
Economic benefits
(demographic dividend)
Normative environment and
ability to realise rights for FP
Stewardship and ownership (e.g.
government and donors, central
and decentralized)
Fragmentation and adequacy of
financing (horizontal and
vertical coherence)
Unmet need
Equity (e.g. poor women and
men, adolescents)
Client continued use (through
method choice)
Financial barriers/out-of-pocket
expenditure
Broad method mix to improve
choice, enable switching, and
reduce discontinuation
FP integration into RMNCAH
continuum/packages

Provider: From whom to purchase

•
•
•

Contracting
Accreditation
Integration (of public and
private providers)

•
•
•
•

Physical access/choice of outlet
Minimum quality standards
Integration of the private sector
Client realization of FP rights

Payment: How to purchase

•
•
•
•
•

Payment rates
Payment methods
Provider autonomy
Claims processing
Quality assurance (data and
clinical)

•

Likelihood of being offered
choice of FP method (e.g. provider behaviour)
Efficiency and quality
Regulatory and public financial
management

outcomes are mitigated. This suggests that as UHC benefits
packages are designed, there is need for the FP community to advocate for more than simple ‘FP inclusion’; the
four ‘Ps’ - package, people, provider and payment - matter
(Mazzilli et al, 2016). Their alignment seeks to reduce OOP
barriers to FP services, improve quality of services with
lower discontinuation rates, and reach all women who have
an unmet need for FP. Common language would facilitate
greater alignment between FP, health financing and purchasing objectives. An organizing framework for common
language is proposed in Table 1. This uses a 5P framework
- package, provider, people, payment and polities - the rationale and institutional arrangements that frame FP service
prioritization.

•
•

REFERENCES
Abt Associates, 2016. Supporting Family Planning within
Universal Health Coverage Initiatives. Consultative Meeting
Highlights, October 27, 2016. Sustaining Health Outcomes
through the Private Sector (SHOPS) Plus.
Appleford, G and S Camara, 2018. Positioning family planning services within health financing and universal health
care in the Sahel, Marie Stopes International, London, UK.
Bangladesh, Ministry of Health and Family Welfare. Directorate General of Family Planning, Ministry of Health
and Family Welfare. http://www.dgfp.gov.bd/site/page/
ca81e7a3-33dd-442b-90bc-da21a34a0c13/History [Retrieved 5/11/2018].
Bellows, N.M., Askew, I. & Bellows, B., 2014. Review of
performance-based incentives in community-based family
planning programmes. The journal of family planning and
reproductive health care, pp.1–6. Available at: http://www.
ncbi.nlm.nih.gov/pubmed/25037703

6

Bellows, B., Bulaya, C., Inambwae, S., Lissner, C. L., Ali,
M., & Bajracharya, A. (2016). Family Planning Vouchers in
Low- and Middle-Income Countries: A Systematic Review.
Studies in Family Planning, 47(4), 357–370.

FP2020a. http://progress.familyplanning2020.org/en/
measurement-section/domestic-government-expenditures-on-family-planning-core-indicator-12 [Retrieved
1/11/2018].

Blacklock, C., E. MacPepple, S. Kunutsor, and S. Witter.
2016. Paying for performance to improve the delivery
and uptake of family planning in low and middle income
countries: A systematic review, Studies in Family Planning
47(4): 390–324.

FP2020b. http://progress.familyplanning2020.
org/en/measurement-section/measuring-components-of-rights-counseling-informed-choice-and-decision-making-core-indicators-14-16 [Retrieved 1/11/2018].

Boydell, V. et al., 2018. Mapping the Extent to Which
Results-Based Financing Programs Reflect a Right-Based
Approach and Implications for Family Planning Services: A
review of indicators, Washington D.C. Report. Washington,
DC: Population Council, The Evidence Project.
Cole, M S, Boydell, V, Bellows, B and K Hardee. 2018.
Mapping the extent to which performance-based financing (PBF) programs reflect quality, informed choice, and
voluntarism and implications for family planning services:
A review of PBF operational manuals, Research Report.
Washington, DC: Population Council, The Evidence Project.
Dieleman, J.L., Schneider, M.T, Haakenstad, A, Singh, L,
Sadat, N, Birger, M, Reynolds, A, Templin, T, Hamavid,
H, Chapin, A, and C J L Murray. Development assistance
for health: past trends, associations, and the future of
international financial flows for health, Lancet 2016; 387:
2536–44.
Eichler, R, Wright, J, Bellows, B, Cole, M, Boydell V and
K. Hardee. 2018. Strategic purchasing to support voluntarism, informed choice, quality and accountability in
family planning: Lessons from results-based financing.
Rockville, MD: Health Finance & Governance Project, Abt
Associates Inc.
Evans and Pablos-Méndez, 2016. Universal Health
Coverage in Africa: A framework for action. Main
report (English). Washington, D.C., World Bank
Group. http://documents.worldbank.org/curated/
en/735071472096342073/Main-report
Fagan, T, Dutta, A, Rosen, J, Olivetti, A and K. Klein, 2017.
Family Planning in the Context of Latin America’s Universal Health Coverage Agenda. Global Health: Science and
Practice.
Ferguson, L and S. Desai, 2018. Sexual and reproductive health and rights for all: translating the Guttmacher-Lancet Commission’s global report to local action,
Reproductive Health Matters, 26:52, 1487621, DOI:
10.1080/09688080.2018.1487621.

Hill, PS, 2018 Primary health care and universal health coverage: competing discourses? The Lancet. Vol.392, Number
10156.
Jain, A K., F Obare, S RamaRao, and I Askew, 2013. Reducing unmet need by supporting women with met need, International Perspective on Sexual and Reproductive Health,
39(3): 133–141.
Jain, A K. and W Winfrey, 2017. Contribution of Contraceptive Discontinuation to Unintended Births in 36 Developing Countries, Studies in Family Planning, doi:10.1111/
sifp.12023
K4Health, Total Market Approach to Family Planning.
https://www.k4health.org/topics/total-market-approach
[Retrieved 1/11/2018].
Karra, M, Canning, D, Hu, J, Ali, M and C. Lissner, 2016.
Community-Based Financing of Family Planning in Developing Countries: A Systematic Review. Studies in Family
Planning, 47(4), 325-341.
Khan, M. E., Hazra, A., Kant, A., & Ali, M. (2016). Conditional and Unconditional Cash Transfers to Improve Use of Contraception in Low- and Middle-Income Countries. Studies in
Family Planning, 47(4), 371–383.
Korachais, C., E. Macouillard, and B. Meessen. 2016. “How
user fees influence contraception in low and middle income
countries: A systematic review,” Studies in Family Planning
47(4): 341–356.
Lawn, JE, Rohde, J, Rifkin, S, Were, M, Paul, VK and M
Chopra, 2008. Alma-Ata 30 years on: revolutionary, relevant, and time to revitalize. Lancet 2008; 372: 917–27
Lie, G.S., Soucat, A.L., Basu, S, 2015. Financing women’s,
children’s, and adolescents’ health. British Medical Journal,
2015 Sep 14;351:h4267.
Maeda A, Araujo E, Cashin C, Harris J, Ikegami N, Reich
MR. Universal health coverage for inclusive and sustainable
development: a synthesis of 11 country case studies. Washington, DC: World Bank, 2014.

7

Mazzili, C, Appleford, G and M. Boxshall. 2016. MSI’s
Health Financing Assessments 2012-2015: What Did We
Learn About UHC Financing and Contraception? Four ‘Ps’
Matter. Marie Stopes International. Available at: https://
mariestopes.org/media/2689/msi-4ps-matter-in-contraception-health-financing.pdf.
Ooms, G, Latif, LA, Waris, A, Brolan, CE, Hammonds, R,
Friedman, EA, Mulumba, M and L. Forman, 2014. BMC International Health and Human Rights, http://www.biomedcentral.com/1472-698X/14/3.
RHSC, 2018. Global Contraceptive Commodity Gap Analysis
2018. Brussels: Reproductive Health Supplies Coalition.
Ross, R., T. Fagan, and A. Dutta. 2018. Is Health Insurance Coverage Associated with Improved Family Planning
Access? A Review of Household Survey Data from Seven
FP2020 Countries. Washington, DC: Palladium, Health
Policy Plus.
RESYST, 2014. What is Strategic Purchasing for Health?
Topic Overview 4, Financing research theme; Resilient and
Responsive Health Systems, London School of Hygiene and
Tropical Medicine, London, UK [Retrieved 3/11/2018].
Schmidt, H, Gostin, LO, and EJ Emanuel, 2015. Public
health, universal health coverage, and Sustainable Development Goals: can they coexist? Lancet 2015; 386: 928–30.
Singh S, JE Darroch, LS Ashford and M Vlassoff, 2009.
Adding It Up: The Costs and Benefits of Investing in Family
Planning and Maternal and Newborn Health, New York:
Guttmacher Institute and United Nations Population Fund.
Sparkes, S., Duran, A. and Kutzin, J.A. 2016. System-wide
Approach to Analysing Efficiency Across Health Programs.
Health Financing Diagnostics and Guidance. World Health
Organisation.
USAID, 2018 (updated). Financing Framework to End Preventable Child and Maternal Deaths. https://www.usaid.
gov/cii/financing-framework-end-preventable-child-and-maternal-deaths-epcmd [Retrieved 1/11/2018].
Witter, S, Govender, V, Ravindran, TKS and R Yates, 2017.
Minding the gaps: health financing, universal health coverage and gender. Health Policy and Planning, 32, v4–v12
doi: 10.1093/heapol/czx063.

World Health Organization. 2010. The World Health Report.
Health Systems Financing the Path to Universal Coverage.
Geneva.
World Health Organisation, 2016. Report by the Secretariat
A69/39. Framework on integrated people-centred health
services. Geneva: World Health Organization.
WHO, 2017. New Perspectives on Global Health Spending
for Universal Health Coverage: Global report. World Health
Organization, Geneva.
Xu K, Saksena P, Holly A,.2011. The determinants of health
expenditure: a country-level panel data analysis.

ACKNOWLEDGMENTS
We thank the David and Lucille Packard Foundation for
their generous support which made this work possible. We
also thank Ben Bellows and Leah Jarvis for their comments.
Suggested citation: Gabrielle Appleford and Saumya
Ramarao, 2019. Health financing and family planning
in the context of Universal Health Care: connecting the
discourse. Population Council, New York.

